Manzo Pharmaceuticals MNZO Stock
Manzo Pharmaceuticals Price Chart
Manzo Pharmaceuticals MNZO Financial and Trading Overview
| Manzo Pharmaceuticals stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0.0001 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 1.0E-5 - 0.0001 USD |
| Volume | 77K USD |
| Avg. Volume | 43.08K USD |
| Market Cap | 500K USD |
| Beta (5Y Monthly) | -65.794 |
| PE Ratio (TTM) | |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MNZO Valuation Measures
| Enterprise Value | 8.72K USD |
| Trailing P/E | |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.002 |
Trading Information
Manzo Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -65.794 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-5 USD |
| 50-Day Moving Average | 7.66E-5 USD |
| 200-Day Moving Average | 9.2E-5 USD |
MNZO Share Statistics
| Avg. Volume (3 month) | 43.08K USD |
| Avg. Daily Volume (10-Days) | 19.21K USD |
| Shares Outstanding | 5B |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2004 |
| Most Recent Quarter (mrq) | March 31, 2011 |
| Next Fiscal Year End | December 31, 2005 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 0 USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -517227 USD |
| EBITDA | -4240974 USD |
| Net Income Avi to Common (ttm) | 7.75M USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 21 USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.202 |
| Book Value Per Share (mrq) | 0 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9173972 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Manzo Pharmaceuticals
| Country | United States |
| State | PA |
| City | Milford |
| Address | PO Box 107 |
| ZIP | 18337 |
| Phone | 570-249-6000 |
| Website | https://www.lactofreedom.com |
| Industry | Shell Companies |
| Sector(s) | Financial Services |
| Full Time Employees | 12 |
Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporated in 1980 and is based in Milford, Pennsylvania.
Q&A For Manzo Pharmaceuticals Stock
What is a current MNZO stock price?
Manzo Pharmaceuticals MNZO stock price today per share is 0.0001 USD.
How to purchase Manzo Pharmaceuticals stock?
You can buy MNZO shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Manzo Pharmaceuticals?
The stock symbol or ticker of Manzo Pharmaceuticals is MNZO.
Which industry does the Manzo Pharmaceuticals company belong to?
The Manzo Pharmaceuticals industry is Shell Companies.
How many shares does Manzo Pharmaceuticals have in circulation?
The max supply of Manzo Pharmaceuticals shares is 5B.
What is Manzo Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Manzo Pharmaceuticals PE Ratio is now.
What was Manzo Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Manzo Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Manzo Pharmaceuticals company belong to?
The Manzo Pharmaceuticals sector is Financial Services.